Case Study Highlights COVID-19 Vaccine-Induced Prothrombotic ITP
Researchers described the case study of a patient with vaccine-induced prothrombotic immune thrombocytopenia.
ITP Insights
Immunosuppression as a Therapeutic Strategy in ITP Examined
The incidence of many rare diseases is rising rapidly, especially in the Western world, and advancements in therapeutics have not quite caught up. In the United States, for example, billions of dollars are being spent annually for treating autoimmune disorders and conducting trials to find future solutions. Immune thrombocytopenia (ITP) is one such disease; it…
COVID-19 Reported in a Patient With Concurrent ITP
The COVID-19 pandemic, which turned the world upside down over a period of roughly 2 years starting from 2020, was a strange period for medicine. On one hand, it seemed that all of medicine had to sit still while COVID-19 was having its moment; hospitals turned into infection camps, elective surgeries were canceled, and routine…
Understanding the Impact of Immune Thrombocytopenia on Quality of Life
Immune thrombocytopenia is an autoimmune disorder characterized by isolated thrombocytopenia resulting from impaired platelet production and increased platelet destruction. The chief goal of treatment is to stop any active bleeds and to prevent future ones from occurring. The main therapies used in this condition are corticosteroids and additional intravenous immunoglobulin in cases of active bleeding. …
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ITP Insights
Loading... 
Loading...